共 50 条
- [1] Effect of gelsolin on cerebral amyloid angiopathy (CAA) in transgenic mice [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2008, 67 (05): : 494 - 494
- [2] Effect of Gelsolin on Cerebral Amyloid Angiopathy (CAA) in Transgenic Mice [J]. FASEB JOURNAL, 2008, 22
- [3] Reducing Available Soluble β-Amyloid Prevents Progression of Cerebral Amyloid Angiopathy in Transgenic Mice [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2012, 71 (11): : 1009 - 1017
- [4] Cerebral amyloid angiopathy in transgenic mouse models [J]. NEUROBIOLOGY OF AGING, 2004, 25 : S46 - S47
- [5] Transgenic mouse models of cerebral amyloid angiopathy [J]. NEUROPATHOLOGY AND GENETICS OF DEMENTIA, 2001, 487 : 123 - 128
- [6] Effect of passive immunotherapy on the rate of progression of cerebral amyloid angiopathy (CAA) in transgenic mice [J]. FASEB JOURNAL, 2007, 21 (05): : A73 - A74
- [7] Effect of passive immunotherapy on the rate of progression of cerebral amyloid angiopathy (caa) in transgenic mice [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2007, 66 (05): : 434 - 435
- [8] Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the London mutant of human APP in neurons [J]. AMERICAN JOURNAL OF PATHOLOGY, 2000, 157 (04): : 1283 - 1298
- [10] Apolipoprotein E transgenic mouse model of cerebral amyloid angiopathy [J]. STROKE, 2001, 32 (01) : 329 - 329